domperidone has been researched along with nicotine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Bianucci, AM; Calderone, V; Coi, A; Massarelli, I; Testai, L | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Rajashekhar, KP; Wilkens, JL | 1 |
| Lajtha, A; Lapin, EP; Maker, HS; Reilly, MA | 1 |
| Pratt, JA; Stolerman, IP | 1 |
| Ikegami, H; Onaivi, ES; Prasad, C; Shimizu, I | 1 |
| Amano, H; Amano, T; Matsubayashi, H; Sasa, M | 1 |
| Bisgard, GE; Herman, JK; Janssen, PL; O'Halloran, KD | 1 |
| Bubl, B; Feuerstein, TJ; Hubbe, U; Huethe, F; Jackisch, R; Löffler, M; McIntosh, JM | 1 |
| Le Foll, B; Novak, G; Seeman, P | 1 |
18 other study(ies) available for domperidone and nicotine
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Identification of "toxicophoric" features for predicting drug-induced QT interval prolongation.
Topics: Amino Acid Sequence; Heart; Humans; Models, Molecular; Molecular Sequence Data; Molecular Structure; Protein Subunits; Sequence Alignment; Structure-Activity Relationship; Trans-Activators; Transcriptional Regulator ERG | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Dopamine and nicotine, but not serotonin, modulate the crustacean ventilatory pattern generator.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Brachyura; Domperidone; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Ganglia; Motor Neurons; Neural Pathways; Nicotine; Receptors, Dopamine D1; Respiration; Serotonin; Thorax | 1992 |
Chronic nicotine administration increases binding of [3H]domperidone in rat nucleus accumbens.
Topics: Animals; Binding Sites; Domperidone; Ketanserin; Male; Nicotine; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Dopamine; Septal Nuclei | 1987 |
Pharmacologically specific pretreatment effects on apomorphine-mediated conditioned taste aversions in rats.
Topics: Animals; Apomorphine; Avoidance Learning; Conditioning, Psychological; Domperidone; Dopamine Antagonists; Drug Interactions; Male; Nicotine; Pimozide; Rats; Taste; Time Factors | 1984 |
Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neurons.
Topics: Aging; Animals; Apomorphine; Benzazepines; Binding Sites; Body Weight; Cellular Senescence; Corpus Striatum; Domperidone; Dopamine; Male; Mazindol; Neurons; Nicotine; Rats; Rats, Inbred F344; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra | 1994 |
Excitation of rat striatal large neurons by dopamine and/or glutamate released from nerve terminals via presynaptic nicotinic receptor (A4beta2 type) stimulation.
Topics: Action Potentials; Animals; Corpus Striatum; Domperidone; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Glutamic Acid; In Vitro Techniques; Neurons; Nicotine; Nicotinic Antagonists; Patch-Clamp Techniques; Perfusion; Presynaptic Terminals; Rats; Receptors, Nicotinic; Receptors, Presynaptic; Stimulation, Chemical | 2001 |
Dopaminergic excitation of the goat carotid body is mediated by the serotonin type 3 receptor subtype.
Topics: Action Potentials; Analysis of Variance; Animals; Blood Pressure; Carotid Body; Carotid Sinus; Cyanates; Domperidone; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Ganglionic Stimulants; Goats; Indoles; Male; Nerve Fibers; Neural Inhibition; Nicotine; Norbornanes; Orchiectomy; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tropisetron | 2003 |
Dopamine release in human neocortical slices: characterization of inhibitory autoreceptors and of nicotinic acetylcholine receptor-evoked release.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adolescent; Adult; Aged; Alkaloids; Analysis of Variance; Animals; Autoreceptors; Azocines; Calcium; Child; Child, Preschool; Domperidone; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Feedback; Female; Fluvoxamine; Humans; In Vitro Techniques; Isoxazoles; Male; Maprotiline; Mice; Middle Aged; Neocortex; Nicotine; Nicotinic Antagonists; Potassium; Pyrrolidines; Quinolizines; Rats; Receptors, Nicotinic; Sulpiride; Time Factors; Tritium | 2006 |
Exposure to nicotine produces an increase in dopamine D2(High) receptors: a possible mechanism for dopamine hypersensitivity.
Topics: Animals; Behavior, Animal; Corpus Striatum; Domperidone; Dopamine; Humans; Male; Nicotine; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Self Administration; Substance Withdrawal Syndrome; Tritium; Up-Regulation | 2010 |